Telix Pharmaceuticals

Melbourne, Australia

Telix Pharmaceuticalsis a clinical-stage biotechnology company focused on the development of diagnostic and therapeutic products.

$600.0M raised

Apr 2026

Post-IPO Debt

Biotechnology

Top Investors

Australian Government

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Telix Pharmaceuticals

How much funding has Telix Pharmaceuticals raised?

Telix Pharmaceuticals has raised $600.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in April 2026.

Who are Telix Pharmaceuticals's investors?

Telix Pharmaceuticals's investors include Australian Government.

Where is Telix Pharmaceuticals headquartered?

Telix Pharmaceuticals is headquartered in Melbourne, Australia.

What does Telix Pharmaceuticals do?

Telix Pharmaceuticalsis a clinical-stage biotechnology company focused on the development of diagnostic and therapeutic products.

What stage is Telix Pharmaceuticals at?

Telix Pharmaceuticals is at the Post-IPO Debt stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 14, 2026.

MLA

"Telix Pharmaceuticals — Funding & Investors." VCBacked, April 14, 2026, https://www.vcbacked.co/company/telix-pharmaceuticals. Accessed July 2, 2026.

APA

VCBacked. (2026). Telix Pharmaceuticals — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/telix-pharmaceuticals

Wikipedia (cite web)

{{cite web |title=Telix Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/telix-pharmaceuticals |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 14, 2026.